PHASE-I TRIAL OF THE COMBINATION OF 6-METHYLMERCAPTOPURINE RIBOSIDE AND 5-FLUOROURACIL

被引：0
|
作者：
WIEMANN, MC
CRABTREE, GW
WEITBERG, AB
SPREMULLI, EN
CUMMINGS, FJ
MURRAY, C
CALABRESI, P
机构：
来源：
MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY | 1988年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：113 / 116
页数：4
相关论文
共 50 条
  • [41] LEUCOVORIN INCREASES THE TOXICITY OF 5-FLUOROURACIL - PHASE-I CLINICAL PHARMACOLOGICAL TRIALS
    BRUCKNER, HW
    STORCH, JA
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 192 - 192
  • [42] 6-methylmercaptopurine riboside, a thiopurine nucleoside with antiviral activity against canine distemper virus in vitro
    de Carvalho, Otavio Valerio
    Felix, Daniele Mendes
    Tozato, Claudia de Camargo
    Rangel Fietto, Juliana Lopes
    de Almeida, Marcia Rogeria
    Bressan, Gustavo Costa
    Pena, Lindomar Jose
    Silva-Junior, Abelardo
    VIROLOGY JOURNAL, 2017, 14
  • [43] A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA ALONE AND IN COMBINATION WITH MYELOSUPPRESSIVE DOSES OF 5-FLUOROURACIL IN PATIENTS WITH GASTROINTESTINAL CANCER
    CROWN, J
    JAKUBOWSKI, A
    KEMENY, N
    GORDON, M
    GASPARETTO, C
    WONG, G
    SHERIDAN, C
    TONER, G
    MEISENBERG, B
    BOTET, J
    APPLEWHITE, J
    SINHA, S
    MOORE, M
    KELSEN, D
    BUHLES, W
    GABRILOVE, J
    BLOOD, 1991, 78 (06) : 1420 - 1427
  • [44] PHASE-I AND PHASE-II TRIAL OF 5-DAY INFUSED 5-FLUOROURACIL AND RADIATION IN ADVANCED CANCER OF THE HEAD AND NECK
    BYFIELD, JE
    SHARP, TR
    FRANKEL, SS
    TANG, SG
    CALLIPARI, FB
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 406 - 413
  • [45] A PHASE-I TRIAL OF INTRAPERITONEAL (IP) 5-FLUOROURACIL (FU) AND FOLINIC ACID (FA) IN GASTROINTESTINAL (GI) TUMORS
    ARBUCK, SG
    TRAVE, F
    DOUGLASS, HO
    BARONI, M
    SILK, Y
    NAVA, H
    FRANK, S
    RUSTUM, YM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 172 - 172
  • [46] CHRONOTHERAPY WITH 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLORECTAL-CARCINOMA - RESULTS OF A CHRONOPHARMACOLOGIC PHASE-I TRIAL
    ADLER, S
    LANG, S
    LANGENMAYER, I
    EIBLEIBESFELDT, B
    RUMP, W
    EMMERICH, B
    HALLEK, M
    CANCER, 1994, 73 (12) : 2905 - 2912
  • [47] A PHASE-I TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, AND DIPYRIDAMOLE GIVEN BY CONCURRENT 120-H CONTINUOUS INFUSIONS
    BAILEY, H
    WILDING, G
    TUTSCH, KD
    ARZOOMANIAN, RZ
    ALBERTI, D
    TOMBES, MB
    GREM, JL
    SPRIGGS, DR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (04) : 297 - 302
  • [48] STUDIES OF COMBINATION 6-MERCAPTOPURINE (NSC-755) AND 6-METHYLMERCAPTOPURINE RIBOSIDE (NSC-40774) IN PATIENTS WITH ACUTE LEUKEMIA AND METASTATIC CANCER
    BODEY, GP
    BRODOVSK.S
    ISASSI, AA
    SAMUELS, ML
    FREIREICH, EJ
    CANCER CHEMOTHERAPY REPORTS, 1968, 52 (02): : 315 - +
  • [49] The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks Zika virus replication
    de Carvalho, Otavio Valerio
    Felix, Daniele Mendes
    de Mendonca, Leila Rodrigues
    Cataldi Sabino de Araujo, Catarina Maria
    de Oliveira Franca, Rafael Freitas
    Cordeiro, Marli Tenorio
    Silva Junior, Abelardo
    Pena, Lindomar Jose
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (06) : 718 - 725
  • [50] PHASE-I STUDY OF A COMBINATION OF AZOTOMYCIN (NSC-56654) AND 5-FLUOROURACIL (NSC-19893) IN MALIGNANT DISEASE
    WEISS, AJ
    MASTRANGELO, MJ
    CANCER CHEMOTHERAPY REPORTS PART 1, 1970, 54 (02): : 109 - +
12345